You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Rheumatoid arthritis - other biologictreatment
SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014401
Mar 2014100
Apr 2014300
May 2014200
Jun 2014100
Sep 2014300
Oct 2014702
Nov 2014601
Dec 2014401
Jan 2015100
Feb 2015700
Mar 2015601
Apr 2015300
Jun 2015300
Jul 2015300
Aug 2015800
Sep 2015300
Oct 2015200
Nov 2015800
Jan 2016704
Feb 2016300
Mar 2016400
Apr 2016400
May 20161001
Jun 20161002
Jul 2016600
Aug 2016300
Sep 2016400
Oct 2016300
Nov 2016600
Dec 2016300
Jan 2017500
Feb 2017300
Mar 2017601
Apr 2017500
May 2017600
Jun 2017500
Aug 2017400
Sep 2017400
Oct 2017400
Nov 2017400
Dec 20172002
Jan 20181001
Feb 2018400
Mar 20181401
Apr 2018600
May 20181201
Jun 2018400
Jul 20181000
Aug 2018800
Sep 2018600
Oct 20182401
Nov 2018200
Dec 20181200
Feb 2019200
Mar 2019600
Apr 2019800
May 2019600
Jun 20191000
Jul 20191604
Aug 2019600
Oct 2019600
Nov 2019400
Jan 2020200
Feb 2020200
Apr 2020200
May 2020800
Sep 2020600
Oct 2020200
Nov 2020400
Dec 2020200
Jan 2021700
Mar 2021200
Apr 2021600
Nov 2021400
Dec 2021600
Jan 2022600
Feb 2022600
Mar 2022200
Apr 2022200
May 2022200
Jun 2022200
Jul 20221800
Aug 2022400
Sep 2022400
Oct 2022600
Nov 2022400
Dec 2022600
Jan 2023600
Feb 2023400
Mar 2023200
Apr 2023600
May 2023400
Jul 2023400
Aug 2023400
Sep 2023800
Dec 20231000
Feb 2024200
Mar 2024400
Total549024